ASH HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSIONS: Venetoclax Plus Azacitidine for Newly Diagnosed Younger AML
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
Speaker
Studies / Trials Discussed
Venetoclax Plus Azacitidine for Newly Diagnosed Younger AML
Studies/trials discussed:
Venetoclax Plus Azacitidine for Newly Diagnosed Younger AML
199 Bay Street #4000
Toronto, ON M5L 1A9
©2025 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement.